NCT01779687View on ClinicalTrials.gov

Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

August 31, 2013

Conditions
HIVHypercholesterolaemia
Interventions
DRUG

raltegravir

Raltegravir 400 mg BID for 7 days

DRUG

Atorvastatin

Atorvastatin 20 mg QD for 7 days

Trial Locations (1)

Unknown

CRCN Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Radboud University Medical Center

OTHER

NCT01779687 - Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin. | Biotech Hunter | Biotech Hunter